-
公开(公告)号:WO02060879A3
公开(公告)日:2003-03-27
申请号:PCT/US0148855
申请日:2001-12-12
Applicant: VERTEX PHARMA , GRILLOT ANNE-LAURE , CHARIFSON PAUL , STAMOS DEAN , LIAO YUSHENG , BADIA MICHAEL , TRUDEAU MARTIN
Inventor: GRILLOT ANNE-LAURE , CHARIFSON PAUL , STAMOS DEAN , LIAO YUSHENG , BADIA MICHAEL , TRUDEAU MARTIN
IPC: C07D235/32 , A61K31/00 , A61K31/4184 , A61K31/423 , A61K31/4245 , A61K31/437 , A61K31/4412 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K45/06 , A61P31/00 , A61P31/04 , A61P43/00 , C07D213/00 , C07D221/00 , C07D235/00 , C07D235/30 , C07D263/58 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/04 , C07D471/04 , C07D471/14 , C07D491/04 , C07D491/056 , C07D498/04 , C07D521/00 , C07F9/6558 , C07F9/6561
CPC classification number: C07D403/12 , A61K31/00 , A61K31/4184 , A61K31/423 , A61K31/437 , A61K31/4439 , A61K31/4709 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K45/06 , C07D231/12 , C07D233/56 , C07D235/30 , C07D249/08 , C07D263/58 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/04 , C07D471/04 , C07D471/14 , C07D491/04 , C07F9/65583 , C07F9/6561 , A61K2300/00
Abstract: The present invention relates to compounds of the formula (I): or a pharmaceutically acceptable derivative or prodrug thereof. The compounds are useful as inhibitors of bacterial gyrase activity. The present invention also relates to methods for treating bacterial infections in mammals. The present invention also relates to methods for decreasing bacterial quantity in a biological sample.
Abstract translation: 本发明涉及式(I)化合物或其药学上可接受的衍生物或前药。 该化合物可用作细菌回旋酶活性的抑制剂。 本发明还涉及用于治疗哺乳动物细菌感染的方法。 本发明还涉及生物样品中细菌数量减少的方法。
-
公开(公告)号:EP1178797A4
公开(公告)日:2003-05-02
申请号:EP00916479
申请日:2000-03-17
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , BADIA MICHAEL , SAUNDERS JEFFREY
IPC: C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653 , A61K31/277 , C07C275/34
CPC classification number: C07C275/40 , C07B2200/07 , C07C275/42 , C07D263/32 , C07F9/653
-
公开(公告)号:CO7250441A2
公开(公告)日:2015-04-30
申请号:CO03050487
申请日:2003-06-13
Applicant: VERTEX PHARMA
Inventor: GRILLOT ANNE-LAIRE , CHARIFSON PAUL , STAMOS DEAN , LIAO YUSHENG , BADIA MICHAEL , TRUDEAU MARTIN
IPC: C07D235/30 , C07D235/32 , A61K31/00 , A61K31/4184 , A61K31/423 , A61K31/4245 , A61K31/437 , A61K31/4412 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K45/06 , A61P31/00 , A61P31/04 , A61P43/00 , C07D213/00 , C07D221/00 , C07D235/00 , C07D263/58 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/04 , C07D471/04 , C07D471/14 , C07D491/04 , C07D491/056 , C07D498/04 , C07D521/00 , C07F9/6558 , C07F9/6561
Abstract: Esta invención se encuentra en el campo de la química medicinal, y se relaciona con los compustos y las composiciones farmacéuticas de los mismos que inhiben las girasas bacterianas. Los compuestos son útiles como inhibidores de la actividad de las girasas bacterianas. Relacionándose con métodos para el tratamiento de infecciones bacterianas en mamíferos permitiendo así disminuir la cantidad de bacterias en las muestras biológicas
-
公开(公告)号:MY138797A
公开(公告)日:2009-07-31
申请号:MYPI20015634
申请日:2001-12-12
Applicant: VERTEX PHARMA
Inventor: GRILLOT ANNE-LAURE , CHARIFSON PAUL , STAMOS DEAN , LIAO YUSHENG , BADIA MICHAEL , TRUDEAU MARTIN
IPC: C07D235/32 , C07D403/04 , A61K31/00 , A61K31/4184 , A61K31/423 , A61K31/4245 , A61K31/437 , A61K31/4412 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K45/06 , A61P31/00 , A61P31/04 , A61P43/00 , C07D213/00 , C07D221/00 , C07D235/00 , C07D235/30 , C07D263/58 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/04 , C07D471/04 , C07D471/14 , C07D491/04 , C07D491/056 , C07D498/04 , C07D521/00 , C07F9/6558 , C07F9/6561
Abstract: THE PRESENT INVENTION RELATES TO COMPOUNDS OF THE FORMULA I:I OR A PHARMACEUTICALLY ACCEPTABLE DERIVATIVE OR PRODRUG THEREOF. THE COMPOUNDS ARE USEFUL AS INHIBITORS OF BACTERIAL GYRASE ACTIVITY. THE PRESENT INVENTION ALSO RELATES TO METHODDS FOR TREATING BACTERIAL INFECTIONS IN MAMMALA. THE PRESENT INVENTION ALSO RELATES TO METHODS FOR DECREASING BACTERIAL QUANTITY IN A BIOLOGICAL SAMPLE.
-
公开(公告)号:SI1251848T1
公开(公告)日:2004-12-31
申请号:SI200130127
申请日:2001-01-16
Applicant: VERTEX PHARMA
Inventor: CHARIFSON PAUL , STAMOS DEAN , BADIA MICHAEL , GRILLOT ANNE-LAURE , RONKIN STEVEN , TRUDEAU MARTIN
IPC: C07D231/38 , A61K31/4155 , A61K31/421 , A61K31/422 , A61K31/427 , A61K31/454 , A61K31/5377 , A61P1/00 , A61P11/00 , A61P13/02 , A61P13/08 , A61P17/00 , A61P17/02 , A61P19/02 , A61P19/08 , A61P25/00 , A61P31/04 , A61P31/06 , A61P43/00 , C07D403/04 , C07D413/04 , C07D417/04 , C07D417/14
Abstract: The present invention relates to compounds of the formula I: where Ring A is a thiazole, oxazole, imidazole or pyrazole and the substituents are as described in the specification, and pharmaceutically acceptable salts thereof. The compounds inhibit bacterial gyrase activity and therefore are useful for treating bacterial infections in mammals.
-
公开(公告)号:TR200401735T4
公开(公告)日:2004-08-23
申请号:TR200401735
申请日:2001-01-16
Applicant: VERTEX PHARMA
Inventor: CHARIFSON PAUL , STAMOS DEAN , BADIA MICHAEL , GRILLOT ANNE-LAURE , RONKIN STEVEN , TRUDEAU MARTIN
IPC: C07D231/38 , A61K31/4155 , A61K31/421 , A61K31/422 , A61K31/427 , A61K31/454 , A61K31/5377 , A61P1/00 , A61P11/00 , A61P13/02 , A61P13/08 , A61P17/00 , A61P17/02 , A61P19/02 , A61P19/08 , A61P25/00 , A61P31/04 , A61P31/06 , A61P43/00 , C07D403/04 , C07D413/04 , C07D417/04 , C07D417/14
Abstract: The present invention relates to compounds of the formula I: where Ring A is a thiazole, oxazole, imidazole or pyrazole and the substituents are as described in the specification, and pharmaceutically acceptable salts thereof. The compounds inhibit bacterial gyrase activity and therefore are useful for treating bacterial infections in mammals.
-
公开(公告)号:EA004141B1
公开(公告)日:2004-02-26
申请号:EA200100992
申请日:2000-03-17
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , BADIA MICHAEL , SAUNDERS JEFFREY
IPC: C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653 , A61K31/277 , C07C275/34 , A61P31/04
Abstract: Настоящееизобретениеотноситсяк соединениям, ингибирующим IMPDH. Данноеизобретениетакжеотноситсяк фармацевтическимкомпозициям, включающимуказанныесоединения. Соединенияи фармацевтическиекомпозициив соответствиис даннымизобретениемособеннохорошоподходятдляингибированияактивностифермента IMPDH и, следовательно, могутбытьнаилучшимобразомиспользованыв качестветерапевтическихагентовдля IMPDH-опосредуемыхпроцессов. Данноеизобретениетакжеотноситсяк способамингибированияактивности IMPDH сприменениемсоединенийв соответствиис настоящимизобретениеми родственныхимсоединений.
-
公开(公告)号:AU769383B2
公开(公告)日:2004-01-22
申请号:AU3757700
申请日:2000-03-17
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , BADIA MICHAEL , SAUNDERS JEFFREY
IPC: C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653 , A61K31/277 , C07C275/34
Abstract: The present invention relates to compounds which inhibit JMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting JMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH-mediated processes. This invention also relates to methods for inhibiting the activity of I1VIPDH using the compounds of this invention and related compounds.
-
公开(公告)号:CO5261612A1
公开(公告)日:2003-03-31
申请号:CO01003497
申请日:2001-01-18
Applicant: VERTEX PHARMA
Inventor: CHARIFSON PAUL S , STAMOS DEAN , BADIA MICHAEL , GRILLOT ANNE-LAURE , RONKIN STEVEN , TRUDEAU MARTIN
IPC: C07D231/38 , A61K31/4155 , A61K31/4178 , A61K31/421 , A61K31/422 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/5377 , A61P1/00 , A61P11/00 , A61P13/02 , A61P13/08 , A61P17/00 , A61P17/02 , A61P19/02 , A61P19/08 , A61P25/00 , A61P31/04 , A61P31/06 , A61P43/00 , C07D403/04 , C07D413/04 , C07D417/04 , C07D417/14
Abstract: Un método para tratar una infección bacterial en un mamífero en necesidad de ello, comprende la etapa de administrar a dicho mamífero una cantidad terapéuticamente efectiva de un compuesto que tiene la fórmula: O una sal farmacéuticamente aceptable de la misma, en donde R1 es un grupo opcionalmente sustituido seleccionado a partir de un grupo alifático con 1 a 6 átomos de carbono, -C(R4)2(CH2)Nnrcor, -C(R4)=N-OR, -C(R4)=N-OC(=O) (C1-6 alifático), C(R4)=NNRCRO, -C(R4)=NN( R )2, -(R4)2(CH2)nNRCO2 (C1-6 alifático), -CO2(C1-6 alifático), -CON(R)2, C(R4)2(CH2)nCON(R)2(CH2)nSO2N(R)2, -C(R4)2(CH2)nSO2N(R)2, -CONH-OR, SO2N(R)2 o -C(R4)2NRSO2(C1-6 alifático), n es cero o uno cada R es independientemente seleccionado de hidrógeno o un grupo alifático C1-6 opcionalmente sustituido; R2 se selecciona de hidrógeno o, cuando R1 es -CO2(C1-3 alifático), R2 se selecciona además de -halo -CN, - C1-4 alifático, un heterocíclico de 3 a 5 miembros, o un heteroarilo de 5 miembros; El anillo A es un anillo de heteroarilo seleccionado de tiazol, oxazol, imidazol o pirazol, en donde dicho imidazol esta opcionalmente unido a un puente C1-3 de un nitrógeno de anillo de imidazol a Ar para formar un anillo fusionado de 5 a 7 miembros; Z es C-R3 o N-R3; R3 es -(CH2)pN(R5)2 o un grupo opcionalmente sustituido seleccionado de C1-6 alifático, heterocíclico, heterocicloalquilo, arilo, aralquilo, heteroarilo o heteroaralquilo; Cada R4 es independientemente seleccionado de hidrógeno, Un grupo alifático C1-6 opcionalmente sustituido, o dos R4 tomados juntos con el carbono al cual ellos están unidos para formar un anillo alifático de 3 a 6 miembros; Cada R5 es independientemente seleccionado de hidrógeno, un grupo alifático C1-4, o dos R5 tomados junto con el nitrógeno al cual ellos están unidos para formar un anillo heterocíclico de 5 a 6 miembros; P es un entero de cero a 4 cuando z es C-R3 o un entero de 1 a 4 cuando z es N-R3; yAr es anillo de arilo heteroarilo, o heterocíclico opcionalmente sustituido.
-
公开(公告)号:BG106020A
公开(公告)日:2002-06-28
申请号:BG10602001
申请日:2001-10-16
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , BADIA MICHAEL , SAUNDERS JEFFREY
IPC: C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653 , A61K31/277 , C07C275/34
Abstract: The present invention relates to compounds, which inhibit IMPDH with formula This invention also relates to pharmaceutical compositions comprising these compounds. The compounds are pharmaceutical compositions of this invention are particularly well suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously use as therapeutic agents for IMPDH-mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds. 28 claims
-
-
-
-
-
-
-
-
-